SCHEMBL21189336

SCHEMBL21189336

Cn1ccc(COC(=O)N[C@H]2CCOc3c(C(=O)Nc4ccc(F)c(F)c4)cccc32)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 5/20 0.37
PTGES O14684 3/20 0.37
RXFP1 Q9HBX9 1/20 0.36
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
PKM P14618 1/20 0.35
BACE1 P56817 1/20 0.34
BACE2 Q9Y5Z0 1/20 0.34
POLB P06746 1/20 0.34
CYP3A4 P08684 1/20 0.34
GAA P10253 1/20 0.34
CYP2C9 P11712 1/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
EPHX2 P34913 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21189353 0.86 PTGES (0.36) TRPV1PTGESRXFP1NPC1RAB9A
SCHEMBL21189251 0.85 TRPV1 (0.37) TRPV1PTGESMAOBNPC1RAB9A
SCHEMBL21189252 0.85 TRPV1 (0.36) TRPV1PTGESRXFP1MAOBNPC1
SCHEMBL19973466 0.85 NPC1 (0.44) NPC1RAB9APOLBTP53HPGD
SCHEMBL21189264 0.85 NPC1 (0.44) NPC1RAB9APOLBTP53HPGD
SCHEMBL21189330 0.85 NPC1 (0.44) NPC1RAB9APOLBTP53HPGD
SCHEMBL21189253 0.85 PTGES (0.37) TRPV1PTGESRXFP1TP53KMT2A
SCHEMBL21189486 0.85 NPC1 (0.45) TRPV1MAOBNPC1RAB9ATP53
SCHEMBL21189326 0.85 NPC1 (0.45) TRPV1MAOBNPC1RAB9ATP53
SCHEMBL21189337 0.84 P2RX7 (0.39) TRPV1PTGESTP53KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS TRPV1 3647/4885PTGES 4518/4885RXFP1 4469/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS TRPV1 3647/4885PTGES 4518/4885RXFP1 4469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.